The Gene Panel Market covers a wide range of targeted genomic testing products and services used to examine multiple genes simultaneously for the identification of genetic variations and disease-related mutations. Gene panels are increasingly used in oncology, hereditary disease testing, pharmacogenomics, rare disease diagnosis, and other areas of precision medicine.
Unlike traditional single-gene testing, gene panels allow healthcare professionals and laboratories to evaluate several genes within a single test. This approach can help improve diagnostic efficiency and provide broader genetic information while reducing the need for multiple individual tests.
The market is being supported by the growing adoption of next-generation sequencing (NGS), increasing demand for precision medicine, rising cancer incidence, expanding genetic screening programs, and improvements in sequencing technologies. The MRFR report estimates that the global Gene Panel Market was valued at USD 3.56 billion in 2025 and is projected to reach USD 14.03 billion by 2035, with a CAGR of 14.58% during 2026–2035.
Get Free Sample PDF Brochure:
Gene Panel Market Sample Request: https://www.marketresearchfuture.com/sample_request/6100
Market Drivers
Growing Adoption of Precision Medicine
The increasing shift toward personalized healthcare is a major factor supporting the Gene Panel Market. Healthcare providers are using genetic information to better understand disease mechanisms, identify inherited risks, and support treatment selection. Gene panels provide a practical approach for evaluating multiple clinically relevant genes in a single workflow.
Rising Cancer Incidence
The increasing global burden of cancer is generating greater demand for molecular and genetic testing. Multi-gene panels can be used to identify hereditary cancer risks and genomic alterations that may help guide treatment decisions. Cancer risk assessment represented the largest application segment in 2025, according to MRFR.
Expansion of Next-Generation Sequencing
Advances in next-generation sequencing have made targeted genetic testing faster and more accessible. Improvements in sequencing throughput, automation, laboratory workflows, and testing economics are helping laboratories adopt gene panels for both clinical and research applications.
Increasing Genetic Screening
Growing awareness of inherited diseases and hereditary cancer syndromes is encouraging the use of multi-gene testing. Genetic screening programs can identify individuals who may have an elevated inherited risk and can support more informed clinical management.
Growing Use of Pharmacogenomics
Pharmacogenomics represents another important growth opportunity. Gene panels can identify genetic variations associated with how individuals respond to specific medicines, supporting more personalized prescribing and medication management.
Expansion of Genomics Programs
Government-backed genomics initiatives and investments in population-scale genetic research are expanding genomic infrastructure across different countries. Such programs can increase laboratory capabilities and create additional demand for sequencing platforms, reagents, testing services, and bioinformatics solutions.
Market Challenges
High Testing and Infrastructure Costs
Although sequencing costs have declined, establishing and maintaining a gene panel testing facility can require significant investment in sequencing equipment, laboratory infrastructure, software, reagents, and trained personnel. Smaller healthcare facilities may therefore rely on external diagnostic laboratories.
Regulatory Complexity
Gene panels involve complex diagnostic technologies and may be subject to regulatory requirements that differ between countries. Manufacturers and laboratories must meet applicable requirements for assay validation, quality control, data management, and clinical use.
Genetic Data Privacy Concerns
Genetic information is highly sensitive and requires appropriate protection. Data breaches, unauthorized access, inadequate consent processes, and differences in privacy regulations across countries can create challenges for laboratories and healthcare organizations.
Shortage of Genetic Counselors and Specialists
The growing use of genetic testing increases the need for professionals capable of explaining test results and their clinical implications. A shortage of genetic counselors, molecular geneticists, and other specialized professionals can create bottlenecks in the testing and interpretation process.
Variant Interpretation Challenges
Gene panels can identify variants whose clinical significance is uncertain. Interpreting these findings requires reliable databases, advanced bioinformatics tools, and specialist expertise. The increasing volume of genetic data makes efficient and accurate variant interpretation an important market requirement.
Browse In-depth Market Research Report on Gene Panel Market:
Gene Panel Market Research Report: https://www.marketresearchfuture.com/reports/gene-panel-market-6100
Market Segmentation
By Product & Services:
Test Kits: Gene panel test kits provide laboratories with standardized reagents and components needed to perform targeted genomic testing. Test kits represented the largest product and services segment in 2025, accounting for 60.05% of market revenue.
Testing Services: Testing services allow hospitals, clinics, research organizations, and other customers to outsource genetic analysis to specialized laboratories. This segment is expected to expand as smaller healthcare organizations increasingly use centralized laboratories for complex sequencing tests.
Bioinformatics and Related Services: Bioinformatics software, data analysis tools, accessories, and interpretation platforms support the processing and clinical interpretation of sequencing results.
By Technique:
Amplicon-Based Approach: Amplicon-based gene panels amplify selected regions of DNA before sequencing. Their relatively straightforward workflow, lower sample requirements, and efficiency make them suitable for targeted testing applications.
Hybridization-Based Approach: Hybridization-based panels use probes to capture selected genomic regions before sequencing. This technique is useful for larger gene panels requiring broad and consistent genomic coverage.
By Design:
Predesigned Gene Panels: Predesigned panels contain established sets of genes selected for specific diseases, conditions, or clinical applications. They can simplify laboratory implementation and provide standardized testing workflows.
Customized Gene Panels: Customized panels allow laboratories and researchers to select specific genes or genomic regions according to their testing requirements. This flexibility is useful for specialized research and clinical applications.
By Application:
Cancer Risk Assessment: Cancer risk assessment is a major application of gene panels. Multi-gene testing can help identify inherited genetic variations associated with hereditary cancer syndromes.
Pharmacogenetics: Pharmacogenetic panels examine genetic variations that may influence medication response. Increasing interest in personalized prescribing is supporting this application.
Rare Disease Testing: Gene panels can help evaluate multiple genes associated with rare and inherited disorders, potentially reducing the need for sequential single-gene testing.
Hereditary Disease Screening: Multi-gene testing can support the identification of inherited conditions and genetic predispositions, particularly where several genes may be associated with a particular disease.
By End User:
Hospitals and Clinics: Hospitals and clinics use gene panels for oncology testing, hereditary disease assessment, molecular diagnostics, and other precision medicine applications. Hospitals and clinics represented 51.98% of the market by end user in 2025.
Diagnostic Laboratories: Specialized diagnostic laboratories perform high-volume genetic testing for hospitals, physicians, research organizations, and other healthcare providers. Outsourcing and centralized testing models are supporting growth in this segment.
Academic and Research Institutions: Universities and research centers use gene panels to investigate genetic diseases, identify biomarkers, conduct population studies, and support translational research.
Pharmaceutical and Biotechnology Companies: Pharmaceutical and biotechnology companies use genomic testing in drug development, biomarker discovery, clinical trials, companion diagnostics, and pharmacogenomic research.
By Region:
North America: North America represents a major regional market due to strong adoption of genomic testing, advanced laboratory infrastructure, favorable reimbursement developments, and extensive use of gene panels in oncology and hereditary disease testing.
Europe: Europe benefits from national genomic medicine programs, expanding genetic testing infrastructure, and increasing adoption of precision medicine. The region also has a strong focus on regulatory compliance and genomic data management.
Asia-Pacific: Asia-Pacific is expected to experience rapid expansion because of government-supported genomics initiatives, increasing healthcare investment, rising cancer incidence, and growing access to advanced sequencing technologies.
South America: South American countries are gradually expanding genomic testing capabilities through public healthcare initiatives, private diagnostic laboratories, and cancer screening programs.
Middle East & Africa: Investment in genomic medicine centers, research infrastructure, and national genome initiatives is creating opportunities for gene panel adoption in selected countries.
Regional Insights
North America
North America held the largest regional share of the Gene Panel Market in 2025, accounting for approximately 38.95% of revenue. The region benefits from advanced molecular diagnostic infrastructure, established sequencing laboratories, and strong demand for oncology and hereditary disease testing.
The United States represents a particularly important market because of its extensive healthcare infrastructure, genetic testing capabilities, research activity, and growing integration of genomic information into clinical care.
Europe
Europe represents another significant market for gene panel technologies. Countries including Germany, the UK, France, Italy, and Spain are expanding genomic medicine capabilities through national healthcare and research programs.
The development of genomic medicine services and cross-border genomics initiatives is supporting demand for targeted sequencing and genetic testing. At the same time, regulatory requirements for in-vitro diagnostic products remain an important consideration for market participants.
Asia-Pacific
Asia-Pacific is expected to record strong growth during the forecast period. MRFR projects a CAGR of 15.25% for the region from 2026 to 2035. Government-backed genomics initiatives in countries such as China, India, and Japan are helping strengthen sequencing infrastructure and increase access to genomic testing.
The increasing cancer burden, expanding healthcare infrastructure, growing research investments, and declining sequencing costs are creating additional opportunities across the region.
South America
South America is developing its genomic testing infrastructure through public healthcare programs and private diagnostic providers. Brazil represents an important market in the region, while other countries are gradually increasing access to molecular diagnostic technologies.
Middle East & Africa
The Middle East and Africa region is at an earlier stage of gene panel adoption but offers long-term opportunities as genomic medicine infrastructure develops. National genome initiatives, investment in specialized medical centers, and international research partnerships can support the expansion of genetic testing.
Key Players
- Illumina, Inc.
- Thermo Fisher Scientific
- F. Hoffmann-La Roche AG
- QIAGEN N.V.
- Agilent Technologies
- Bio-Rad Laboratories
- BGI Genomics
- Myriad Genetics
- Invivoscribe, Inc.
- Guardant Health
These companies participate across areas such as sequencing platforms, targeted gene panel kits, molecular diagnostics, bioinformatics, oncology testing, hereditary disease testing, and liquid biopsy applications.
Future Outlook
The Gene Panel Market is expected to continue expanding as genomic testing becomes increasingly integrated into precision medicine, oncology, hereditary disease screening, and pharmacogenomics. According to the current MRFR report, the market is projected to increase from USD 3.56 billion in 2025 to USD 14.03 billion by 2035, representing a CAGR of 14.58% during 2026–2035.
The continued development of next-generation sequencing is likely to improve testing speed, throughput, and accessibility. At the same time, artificial intelligence and advanced bioinformatics can support the interpretation of increasingly complex genomic datasets.
The convergence of gene panels with liquid biopsy technologies may create additional opportunities in cancer monitoring and treatment management. Pharmacogenomic testing and expanded newborn screening programs also represent areas where targeted genomic testing could gain broader clinical applications.
Emerging markets across Asia-Pacific, Southeast Asia, South America, and Africa may provide additional opportunities as laboratory infrastructure improves and sequencing becomes more affordable. Overall, increasing demand for personalized healthcare, expanding genomic research, and continued technological innovation are expected to shape the long-term development of the global Gene Panel Market.
Related Reports:
Explore key developments shaping industry transformation:
Lentiviral Vector Contract Development Manufacturing Organization Market Trends
Pharmaceutical Suppositorie Market Growth
Anti-Snoring Device Market Demand
Active Pharmaceutical Ingredient CDMO Market Forecast
About Market Research Future:
Market Research Future (MRFR) is a global market research company providing market intelligence and industry analysis across healthcare, life sciences, technology, and other sectors. Its research reports examine market trends, technologies, applications, regional developments, competitive landscapes, and growth opportunities.
MRFR research is designed to help organizations understand evolving markets, assess business opportunities, evaluate industry dynamics, and support strategic planning.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
